PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+13.94%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.71B
AUM Growth
+$3.71B
(+23%)
Cap. Flow
+$334M
Cap. Flow
% of AUM
9.01%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
129
New
34
Increased
28
Reduced
23
Closed
29
Top Buys
| 1 |
Liberty Global Class A
LBTYA
|
$111M |
| 2 |
Marvell Technology
MRVL
|
$98.2M |
| 3 |
CSC
Computer Sciences
CSC
|
$98M |
| 4 |
Alibaba
BABA
|
$87.3M |
| 5 |
Universal Health Services
UHS
|
$86.9M |
Top Sells
| 1 |
Range Resources
RRC
|
$86.2M |
| 2 |
Cigna
CI
|
$68.9M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
$63.7M |
| 4 |
Salesforce
CRM
|
$63M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$53.4M |
Sector Composition
| 1 | Healthcare | 41.49% |
| 2 | Technology | 11.44% |
| 3 | Communication Services | 6.69% |
| 4 | Energy | 4.91% |
| 5 | Consumer Discretionary | 4.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Marvell Technology
MRVL
$54.2B
| $129M | 3.24% | 8,479,622 +6,433,672 | +314% | +$98.2M |
|
2
Jazz Pharmaceuticals
JAZZ
$7.75B
| $125M | 3.14% | 864,276 -68,847 | -7% | -$9.99M |
|
|
3
Liberty Global Class A
LBTYA
$4B
| $111M | 2.77% | +3,089,161 | New | +$111M |
|
4
Biogen
BIIB
$19.4B
| $107M | 2.67% | 390,664 -195,046 | -33% | -$53.3M |
|
|
WFT
5
DELISTED
Weatherford International plc
WFT
| $102M | 2.55% | 15,289,479 +7,404,913 | +94% | +$49.2M |
|
|
CSC
6
DELISTED
Computer Sciences
CSC
| $98M | 2.45% | +1,420,281 | New | +$98M |
|
|
MDCO
7
DELISTED
Medicines Co
MDCO
| $90.5M | 2.27% | 1,850,635 -866,806 | -32% | -$42.4M |
|
|
8
Alibaba
BABA
$322B
| $87.3M | 2.19% | +810,019 | New | +$87.3M |
|
|
9
Universal Health Services
UHS
$11.6B
| $86.9M | 2.18% | +697,958 | New | +$86.9M |
|
10
BioMarin Pharmaceuticals
BMRN
$11.2B
| $86.3M | 2.16% | 983,126 -74,433 | -7% | -$6.53M |
|
11
Humana
HUM
$36.5B
| $81.4M | 2.04% | 394,842 +43,051 | +12% | +$8.87M |
|
12
Starbucks
SBUX
$100B
| $77.5M | 1.94% | +1,327,769 | New | +$77.5M |
|
13
Pacira BioSciences
PCRX
$1.2B
| $74.2M | 1.86% | 1,627,277 +466,302 | +40% | +$21.3M |
|
14
Elevance Health
ELV
$71.8B
| $72.8M | 1.82% | 440,126 -96,331 | -18% | -$15.9M |
|
15
GoDaddy
GDDY
$20.5B
| $67.4M | 1.69% | 1,779,472 +1,492,510 | +520% | +$56.6M |
|
|
KITE
16
DELISTED
Kite Pharma, Inc.
KITE
| $66.4M | 1.66% | 845,393 -152,071 | -15% | -$11.9M |
|
|
PTLA
17
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $66.3M | 1.66% | 1,692,510 +1,114,360 | +193% | +$43.7M |
|
|
SLCA
18
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $64.8M | 1.62% | 1,350,636 +493,765 | +58% | +$23.7M |
|
|
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
| $64.1M | 1.6% | 1,006,472 -272,383 | -21% | -$17.3M |
|
20
Baxter International
BAX
$12.7B
| $60.3M | 1.51% | +1,162,488 | New | +$60.3M |
|
21
Heron Therapeutics
HRTX
$207M
| $59M | 1.48% | 3,932,730 +1,199,453 | +44% | +$18M |
|
|
AERI
22
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $58.6M | 1.47% | 1,293,129 -142,626 | -10% | -$6.47M |
|
|
TFCFA
23
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $53.9M | 1.35% | +1,663,321 | New | +$53.9M |
|
24
Hologic
HOLX
$14.9B
| $51.6M | 1.29% | 1,213,261 +159,474 | +15% | +$6.79M |
|
25
UnitedHealth
UNH
$281B
| $51.4M | 1.29% | 313,398 -214,167 | -41% | -$35.1M |
|